Cargando…
Sex Differences in the Pro-Angiogenic Response of Human Endothelial Cells: Focus on PFKFB3 and FAK Activation
Female hormones and sex-specific factors are established determinants of endothelial function, yet their relative contribution to human endothelium phenotypes has not been defined. Using human umbilical vein endothelial cells (HUVECs) genotyped by donor's sex, we investigated the influence of s...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773665/ https://www.ncbi.nlm.nih.gov/pubmed/33390959 http://dx.doi.org/10.3389/fphar.2020.587221 |
_version_ | 1783630092989104128 |
---|---|
author | Boscaro, Carlotta Trenti, Annalisa Baggio, Chiara Scapin, Chiara Trevisi, Lucia Cignarella, Andrea Bolego, Chiara |
author_facet | Boscaro, Carlotta Trenti, Annalisa Baggio, Chiara Scapin, Chiara Trevisi, Lucia Cignarella, Andrea Bolego, Chiara |
author_sort | Boscaro, Carlotta |
collection | PubMed |
description | Female hormones and sex-specific factors are established determinants of endothelial function, yet their relative contribution to human endothelium phenotypes has not been defined. Using human umbilical vein endothelial cells (HUVECs) genotyped by donor's sex, we investigated the influence of sex and estrogenic agents on the main steps of the angiogenic process and on key proteins governing HUVEC metabolism and migratory properties. HUVECs from female donors (fHUVECs) showed increased viability (p < 0.01) and growth rate (p < 0.01) compared with those from males (mHUVECs). Despite higher levels of G-protein coupled estrogen receptor (GPER) in fHUVECs (p < 0.001), treatment with 17β-estradiol (E2) and the selective GPER agonist G1 (both 1–100 nM) did not affect HUVEC viability. Migration and tubularization in vitro under physiological conditions were higher in fHUVECs than in mHUVECs (p < 0.05). E2 treatment (1–100 nM) upregulated the glycolytic activator PFKFB3 with higher potency in fHUVECs than in mHUVECs, despite comparable baseline levels. Moreover, Y576/577 phosphorylation of focal adhesion kinase (FAK) was markedly enhanced in fHUVECs (p < 0.001), despite comparable Src activation levels. While the PI3K inhibitor LY294002 (25 µM) inhibited HUVEC migration (p < 0.05), Akt phosphorylation levels in fHUVECs and mHUVECs were comparable. Finally, digitoxin treatment, which inhibits Y576/577 FAK phosphorylation, abolished sexual dimorphism in HUVEC migration. These findings unravel complementary modulation of HUVEC functional phenotypes and signaling molecules involved in angiogenesis by hormone microenvironment and sex-specific factors, and highlight the need for sex-oriented pharmacological targeting of endothelial function. |
format | Online Article Text |
id | pubmed-7773665 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-77736652021-01-01 Sex Differences in the Pro-Angiogenic Response of Human Endothelial Cells: Focus on PFKFB3 and FAK Activation Boscaro, Carlotta Trenti, Annalisa Baggio, Chiara Scapin, Chiara Trevisi, Lucia Cignarella, Andrea Bolego, Chiara Front Pharmacol Pharmacology Female hormones and sex-specific factors are established determinants of endothelial function, yet their relative contribution to human endothelium phenotypes has not been defined. Using human umbilical vein endothelial cells (HUVECs) genotyped by donor's sex, we investigated the influence of sex and estrogenic agents on the main steps of the angiogenic process and on key proteins governing HUVEC metabolism and migratory properties. HUVECs from female donors (fHUVECs) showed increased viability (p < 0.01) and growth rate (p < 0.01) compared with those from males (mHUVECs). Despite higher levels of G-protein coupled estrogen receptor (GPER) in fHUVECs (p < 0.001), treatment with 17β-estradiol (E2) and the selective GPER agonist G1 (both 1–100 nM) did not affect HUVEC viability. Migration and tubularization in vitro under physiological conditions were higher in fHUVECs than in mHUVECs (p < 0.05). E2 treatment (1–100 nM) upregulated the glycolytic activator PFKFB3 with higher potency in fHUVECs than in mHUVECs, despite comparable baseline levels. Moreover, Y576/577 phosphorylation of focal adhesion kinase (FAK) was markedly enhanced in fHUVECs (p < 0.001), despite comparable Src activation levels. While the PI3K inhibitor LY294002 (25 µM) inhibited HUVEC migration (p < 0.05), Akt phosphorylation levels in fHUVECs and mHUVECs were comparable. Finally, digitoxin treatment, which inhibits Y576/577 FAK phosphorylation, abolished sexual dimorphism in HUVEC migration. These findings unravel complementary modulation of HUVEC functional phenotypes and signaling molecules involved in angiogenesis by hormone microenvironment and sex-specific factors, and highlight the need for sex-oriented pharmacological targeting of endothelial function. Frontiers Media S.A. 2020-12-17 /pmc/articles/PMC7773665/ /pubmed/33390959 http://dx.doi.org/10.3389/fphar.2020.587221 Text en Copyright © 2020 Boscaro, Trenti, Scapin, Baggio, Trevisi, Cignarella and Bolego http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Boscaro, Carlotta Trenti, Annalisa Baggio, Chiara Scapin, Chiara Trevisi, Lucia Cignarella, Andrea Bolego, Chiara Sex Differences in the Pro-Angiogenic Response of Human Endothelial Cells: Focus on PFKFB3 and FAK Activation |
title | Sex Differences in the Pro-Angiogenic Response of Human Endothelial Cells: Focus on PFKFB3 and FAK Activation |
title_full | Sex Differences in the Pro-Angiogenic Response of Human Endothelial Cells: Focus on PFKFB3 and FAK Activation |
title_fullStr | Sex Differences in the Pro-Angiogenic Response of Human Endothelial Cells: Focus on PFKFB3 and FAK Activation |
title_full_unstemmed | Sex Differences in the Pro-Angiogenic Response of Human Endothelial Cells: Focus on PFKFB3 and FAK Activation |
title_short | Sex Differences in the Pro-Angiogenic Response of Human Endothelial Cells: Focus on PFKFB3 and FAK Activation |
title_sort | sex differences in the pro-angiogenic response of human endothelial cells: focus on pfkfb3 and fak activation |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773665/ https://www.ncbi.nlm.nih.gov/pubmed/33390959 http://dx.doi.org/10.3389/fphar.2020.587221 |
work_keys_str_mv | AT boscarocarlotta sexdifferencesintheproangiogenicresponseofhumanendothelialcellsfocusonpfkfb3andfakactivation AT trentiannalisa sexdifferencesintheproangiogenicresponseofhumanendothelialcellsfocusonpfkfb3andfakactivation AT baggiochiara sexdifferencesintheproangiogenicresponseofhumanendothelialcellsfocusonpfkfb3andfakactivation AT scapinchiara sexdifferencesintheproangiogenicresponseofhumanendothelialcellsfocusonpfkfb3andfakactivation AT trevisilucia sexdifferencesintheproangiogenicresponseofhumanendothelialcellsfocusonpfkfb3andfakactivation AT cignarellaandrea sexdifferencesintheproangiogenicresponseofhumanendothelialcellsfocusonpfkfb3andfakactivation AT bolegochiara sexdifferencesintheproangiogenicresponseofhumanendothelialcellsfocusonpfkfb3andfakactivation |